| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 777.30M | 754.43M | 719.15M | 641.81M | 569.16M |
| Gross Profit | 382.70M | 371.93M | 339.10M | 291.73M | 262.77M |
| EBITDA | 206.20M | 163.21M | 169.94M | 148.67M | 133.48M |
| Net Income | 115.40M | 103.58M | 113.14M | 93.24M | 80.25M |
Balance Sheet | |||||
| Total Assets | 813.80M | 780.49M | 773.78M | 735.73M | 676.15M |
| Cash, Cash Equivalents and Short-Term Investments | 110.00M | 149.98M | 146.37M | 114.77M | 123.47M |
| Total Debt | 44.70M | 24.65M | 11.96M | 8.84M | 9.34M |
| Total Liabilities | 229.40M | 181.98M | 151.49M | 145.83M | 142.07M |
| Stockholders Equity | 581.60M | 595.78M | 620.59M | 588.48M | 534.08M |
Cash Flow | |||||
| Free Cash Flow | 116.20M | 128.83M | 113.09M | 46.55M | 65.27M |
| Operating Cash Flow | 125.60M | 148.77M | 124.89M | 59.45M | 85.42M |
| Investing Cash Flow | -44.90M | -12.95M | -23.46M | -6.84M | -12.24M |
| Financing Cash Flow | -118.70M | -129.47M | -64.85M | -62.39M | -136.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.52B | 8.69 | 20.10% | 7.92% | ― | ― | |
74 Outperform | £6.59B | 20.02 | 24.91% | 1.29% | -0.32% | -3.96% | |
71 Outperform | £1.85B | 15.43 | 33.12% | 1.01% | 24.42% | 103.25% | |
66 Neutral | £7.42B | 29.17 | 13.46% | 1.93% | -6.93% | 18.57% | |
64 Neutral | £7.37B | 29.74 | 13.42% | 1.26% | -1.97% | 40.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £4.94B | 30.76 | 13.88% | 2.46% | 0.10% | -15.33% |